Renzenbrink & Partner has advised Klingel medical metal Group (backed by IK funds) on the acquisition of two Swiss “MedTech” companies

10 April 2019

Renzenbrink & Partner has advised Klingel Holding GmbH, an IK portfolio company, on the
acquisition of the Swiss “MedTech” companies Bächler Feintech AG (“Bächler”) and Gehring
Cut AG (“Gehring”).

Bächler was founded in 1964 and has approx. 140 employees at its production site in Hölstein,
Switzerland. Gehring was founded in 1948 and has approx. 75 employees at its production site
in Matzingen, Switzerland. Both companies are leading manufacturers of high-precision
surgical instruments for the global MedTech market.

Klingel medical metal Group, one of the leading European precision technology providers with
a strategic focus on MedTech and more than 300 employees in Germany, is a portfolio company
of funds advised by the IK Investment Partners Fund VIII (“IK”). Klingel medical metal Group
specializes in the precision processing of materials with low machinability, such as titanium
and high-grade stainless steel.

Renzenbrink & Partner advised IK in 2018 on all legal and tax aspects of the acquisition of
Klingel medical metal Group. For the add-on acquisitions of Bächler and Gehring, Renzenbrink
acted as lead counsel and co-advised Klingel Holding GmbH together with Swiss law firms
Wenger & Vieli AG (Bächler) and Wiesli Rechtsanwälte (Gehring) on all aspects of the
transactions, including the management equity package. The team included Dr Ulf
Renzenbrink and Dr Niels Maier (Corporate/M&A) as well as Marc H. Kotyrba (Tax).